The Research Institute of the Hospital de la Santa Creu i Sant Pau (HSCSP-IR) participates in the Project KPI002-PCOS: focused in developing a new product for the treatment of Polycystic Ovary Syndrome, expedient number RTC-20016-2671-1 developed in collaboration with: KERN PHARMA and The Foundation Sant Joan de Déu for the Research and Teaching (FSJD), and is being co-financed by:
